Global Prostate Cancer Therapeutics Market Analysis and Forecast
The global prostate cancer therapeutics market was valued at USD 13.4 billion in 2024, and it is projected to expand at a compound annual growth rate (CAGR) of 8.6% from 2025 to 2030. This anticipated growth is primarily attributed to several key factors, including the increasing incidence of prostate cancer worldwide, advancements in early detection through improved screening and diagnostic technologies, and supportive government initiatives that promote the development and approval of new treatments. In recent years, the integration of cutting-edge technologies such as bioinformatics and computational biology has significantly enhanced the landscape of therapy development. Leading industry players are utilizing sophisticated techniques, including proteome profiling and genome sequencing, to innovate and refine therapeutic solutions. A notable example is a phase III clinical trial conducted in 2022, which involved more than 4,000 male participants. This trial asses...